This Blog is also available as an
RSS Feed
Lives Depend on Such Stocks
4 June 2008 - News - EditorDoes your portfolio have Biotechnology & Drugs Industry stocks? It seems to be a risky business for some. The industry stock price index is up just 1% for the 12 months ended mid-May 2008. This is against a 2.5% corresponding gain for the S&P500.
It would be naïve to write off the Biotechnology & Drugs Industry. Insiders believe that it is the future face of the entire Healthcare Sector. Most companies in the business of gene therapy are less than two decades old. That is simply not long enough for an industry with such tough regulatory hurdles.
Biotechnology & Drugs Industry stock investing calls for stereo expertise. The domains of science and finance are equally potent. It is not the usual stuff average stock brokers know. Are you ready for an example?
Consider Alnylam Pharmaceuticals Incorporated (NASDAQ: ALNY). The company has the impressive base of Cambridge, MA. It has been founded by top research scientists. The company is named after a star which is part of the Orion. It is 250 thousand times brighter than our sun. The central pyramid of the Giza in Egypt is aligned with this star. The symbolism is appropriate. ALNY has some of the top business prospects in the Biotechnology & Drugs firmament. It is not just a matter of money. ALNY is involved with treating liver cancer, viral infections in the lungs, and inherited disorders that impair some functions of the brain.
Annual sales have crossed $50 million with a 100% Gross Margin. The management has licensed enabling technologies for its lead candidate drugs, negotiated favorable partnerships with the global pharmaceutical industry, and won important U.S. government support as well.
Write to us if you have spotted another such star in the Biotechnology & Drugs Industry sky.
- Video: Van Cleef & Arpels CEO on Business Strategy, China
- Monday 21 May 2012, 12:00 pm - Video: Facebook Stock Price Is `Worrisome,' Says Chervitz
- Monday 21 May 2012, 11:06 am - Video: Banks Don't Belong in Risky Assets, Angelides Says
- Monday 21 May 2012, 11:03 am - Video: Edward Conard on Bank Industry Outlook, Economy
- Monday 21 May 2012, 10:26 am - Video: Heineken Sales 60% About Emotion, 40% About Beer
- Monday 21 May 2012, 8:31 am - Video: Greek Euro Exit Would Benefit Ryanair; Irish Vote
- Monday 21 May 2012, 8:20 am
- Jobs Market Continues to Sway Investors
- Thursday 3 may 2012 - Features - July 2014 Compliance for Volcker Rule
- Friday 20 April 2012 - Markets - JOBS Act - Easing Regulations for Growth
- Thursday 5 April 2012 - News - FHFA to Bulk-Sell Foreclosed Homes
- Thursday 22 March 2012 - News - High Frequency Trading
- Thursday 8 March 2012 - Features - Stock Exchange Listing and Delisting
- Thursday 23 February 2012 - Features
jalith: need the information how to start invest in stock market...
www.stockmarkets.com/personal-finance/
StockMarkets.com Team: Thank you for visiting StockMarkets.com. We do not represent the South Pacific Stock Exchange, so pl...
www.stockmarkets.com/exchanges/australasia/south-pacific-exchange/
milika: Can you please give me the listed companies that are in SPSE for my assignment purpose because it is...
www.stockmarkets.com/exchanges/australasia/south-pacific-exchange/
bob: you make loud boasts , but can you show me the opening and closing of the market indexs in South Ame...
www.stockmarkets.com/exchanges/south-america/
kennedy edahdike: with a dynamic emerging global power,a bouyant stock market is a sine qua non for develpoment,the po...
www.stockmarkets.com/exchanges/asia/chinese-stock-exchange/


Airplanes
Auto Racing
Birds
China Trade
Horse Racing
Musicians
Snow Skiing
Algeria
Ecuador
Bangladesh
Morocco
Nepal
Nicaragua
Puerto Rico
Russia
Scotland
South Africa
Ukraine
Virtual Countries
User Comments & Reviews: 0 Comment(s)
Leave a comment: